Egg Development Study: Testing a New Hormone Signal
Treatments studied
Part of Bones, joints & muscles, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This research study looks at how a specific hormone signal affects egg development in the ovary. Researchers are trying to understand if changing this signal might improve egg quality or fertility outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older
- You have normal AMH levels (a hormone that reflects ovarian reserve)
- You are able to provide informed consent to participate
- You have not had ovarian tissue surgically transplanted back into your body
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two injectable medications (romosozumab and abaloparatide) that help strengthen bones in women after menopause. Researchers will also look at blood markers to understand why some women respond better to treatment than others.
This study tests whether a supplement called NMN can improve pregnancy outcomes for women with low ovarian reserve who are undergoing IVF or ICSI. It's designed for women who have been told they have a low egg supply and are looking for options to increase their chances.
This study looks at whether a hormone level measured inside the fluid around eggs (follicular fluid) can predict whether embryos have the correct number of chromosomes. It may help clinics choose which embryos are more likely to be healthy.
This trial studies whether an injection of your own “platelet-rich” plasma into the ovaries can improve egg production in people who respond poorly to fertility treatment. It targets women with low egg reserve and tries to see if this approach helps them get better results from stimulation.
This study tests a new way to give a fertility hormone (FSH) in pulses through a small tube to see if it helps women with obesity or low egg reserve have better egg development with fewer health risks. It may improve fertility treatment outcomes for these women.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.